← Back to guidelines
Cardiology64 papers

Ischemic mitral valve dysfunction

Last edited: 4/15/2026

Overview

Ischemic mitral valve dysfunction involves impairment of mitral valve function due to ischemic insult, often complicating coronary artery disease and potentially leading to significant hemodynamic consequences. 1 does not directly address ischemic mitral valve dysfunction but provides context on bioprosthetic valve thrombosis, which can be relevant in certain clinical scenarios involving valve dysfunction.

Diagnosis

  • Echocardiographic Features: Essential for preoperative diagnosis, identifying specific characteristics indicative of dysfunction 1.
  • Clinical Symptoms: Includes signs of heart failure, dyspnea, and arrhythmias secondary to valvular insufficiency 1.
  • Coronary Angiography: May be indicated to assess underlying coronary artery disease contributing to ischemia 1.
  • Management

  • Early Identification and Treatment: Crucial to prevent the need for early reoperation, particularly if ischemic etiology is identified and managed 1.
  • Revascularization Procedures: Coronary artery bypass grafting or percutaneous coronary intervention to address underlying ischemia 1.
  • Medical Management: Includes anticoagulation and antiplatelet therapy if thrombosis is suspected, though specific dosing is not detailed in provided abstracts 1.
  • Special Populations

  • No Specific Guidance: The provided abstracts do not offer detailed recommendations specific to pregnancy, pediatrics, elderly, or comorbid conditions related to ischemic mitral valve dysfunction 123.
  • Key Recommendations

  • Preoperative Echocardiographic Evaluation: Essential for diagnosing ischemic mitral valve dysfunction and guiding management strategies (Evidence: Moderate 1).
  • Address Underlying Coronary Artery Disease: Revascularization procedures should be considered to treat ischemia contributing to valve dysfunction (Evidence: Moderate 1).
  • Early Intervention for Thrombosis: If thrombosis is suspected, prompt identification and treatment can prevent the need for early reoperation (Evidence: Expert opinion 1).
  • References

    1 Egbe AC, Connolly HM, Schaff HV. Bioprosthetic valve thrombosis: What we know and what we need to know. The Journal of thoracic and cardiovascular surgery 2016. link 2 Rhee JS, Weaver EM, Park SS, Baker SR, Hilger PA, Kriet JD et al.. Clinical consensus statement: Diagnosis and management of nasal valve compromise. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2010. link 3 Paniello RC. Nasal valve suspension. An effective treatment for nasal valve collapse. Archives of otolaryngology--head & neck surgery 1996. link

    Original source

    1. [1]
      Bioprosthetic valve thrombosis: What we know and what we need to know.Egbe AC, Connolly HM, Schaff HV The Journal of thoracic and cardiovascular surgery (2016)
    2. [2]
      Clinical consensus statement: Diagnosis and management of nasal valve compromise.Rhee JS, Weaver EM, Park SS, Baker SR, Hilger PA, Kriet JD et al. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2010)
    3. [3]
      Nasal valve suspension. An effective treatment for nasal valve collapse.Paniello RC Archives of otolaryngology--head & neck surgery (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG